KYLIE SCHUCK: Open Payments
NPI 1013629872 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 84 payments from 23 companies in 2025. Trend: 2023 $1,133 · 2024 $2,129 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $287 |
| ABBVIE INC. | 13 | $239 |
| PFIZER INC. | 8 | $158 |
| Novo Nordisk Inc | 8 | $144 |
| Lilly USA, LLC | 4 | $130 |
| Corcept Therapeutics | 5 | $101 |
| Sumitomo Pharma America, Inc. | 4 | $97 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Dexcom, Inc. | 3 | $79 |
Products named: BREZTRI, VRAYLAR, Korlym, GEMTESA, LEQVIO, JARDIANCE, Dexcom G6 Transmitter, QULIPTA.
Industry payments across NC — which companies pay providers there.
